These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 7559308

  • 1. Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report.
    Lombroso PJ, Scahill L, King RA, Lynch KA, Chappell PB, Peterson BS, McDougle CJ, Leckman JF.
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1147-52. PubMed ID: 7559308
    [Abstract] [Full Text] [Related]

  • 2. Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study.
    Cubo E, Fernández Jaén A, Moreno C, Anaya B, González M, Kompoliti K.
    Clin Ther; 2008 Jan; 30(1):182-9. PubMed ID: 18343255
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness and safety of risperidone for children and adolescents with chronic tic or tourette disorders in Korea.
    Kim BN, Lee CB, Hwang JW, Shin MS, Cho SC.
    J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):318-24. PubMed ID: 15910216
    [Abstract] [Full Text] [Related]

  • 4. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH.
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [Abstract] [Full Text] [Related]

  • 5. Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial.
    Gilbert DL, Batterson JR, Sethuraman G, Sallee FR.
    J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):206-14. PubMed ID: 14726728
    [Abstract] [Full Text] [Related]

  • 6. Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome.
    Gaffney GR, Perry PJ, Lund BC, Bever-Stille KA, Arndt S, Kuperman S.
    J Am Acad Child Adolesc Psychiatry; 2002 Mar; 41(3):330-6. PubMed ID: 11886028
    [Abstract] [Full Text] [Related]

  • 7. Risperidone-induced obsessive-compulsive symptoms in two children.
    Diler RS, Yolga A, Avci A, Scahill L.
    J Child Adolesc Psychopharmacol; 2003 Mar; 13 Suppl 1():S89-92. PubMed ID: 12880504
    [Abstract] [Full Text] [Related]

  • 8. Chronic tics and Tourette syndrome in patients with obsessive-compulsive disorder.
    Diniz JB, Rosario-Campos MC, Hounie AG, Curi M, Shavitt RG, Lopes AC, Miguel EC.
    J Psychiatr Res; 2006 Sep; 40(6):487-93. PubMed ID: 16289552
    [Abstract] [Full Text] [Related]

  • 9. An open-label, prospective study of guanfacine in children with ADHD and tic disorders.
    Boon-yasidhi V, Kim YS, Scahill L.
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S156-62. PubMed ID: 16856436
    [Abstract] [Full Text] [Related]

  • 10. Determinants of quality of life in children with Gilles de la Tourette syndrome.
    Bernard BA, Stebbins GT, Siegel S, Schultz TM, Hays C, Morrissey MJ, Leurgans S, Goetz CG.
    Mov Disord; 2009 May 15; 24(7):1070-3. PubMed ID: 19306279
    [Abstract] [Full Text] [Related]

  • 11. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome.
    Bloch MH, Peterson BS, Scahill L, Otka J, Katsovich L, Zhang H, Leckman JF.
    Arch Pediatr Adolesc Med; 2006 Jan 15; 160(1):65-9. PubMed ID: 16389213
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The relationship between tic disorders and Tourette's syndrome revisited.
    Spencer T, Biederman J, Harding M, Wilens T, Faraone S.
    J Am Acad Child Adolesc Psychiatry; 1995 Sep 15; 34(9):1133-9. PubMed ID: 7559306
    [Abstract] [Full Text] [Related]

  • 15. Risperidone as a treatment for Tourette's syndrome.
    Bruun RD, Budman CL.
    J Clin Psychiatry; 1996 Jan 15; 57(1):29-31. PubMed ID: 8543544
    [Abstract] [Full Text] [Related]

  • 16. Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide.
    Lipinski JF, Sallee FR, Jackson C, Sethuraman G.
    Mov Disord; 1997 May 15; 12(3):402-7. PubMed ID: 9159736
    [Abstract] [Full Text] [Related]

  • 17. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
    Masi G, Gagliano A, Siracusano R, Berloffa S, Calarese T, Ilardo G, Pfanner C, Magazù A, Cedro C.
    J Child Adolesc Psychopharmacol; 2012 Apr 15; 22(2):120-5. PubMed ID: 22375853
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Life events and Tourette syndrome.
    Steinberg T, Shmuel-Baruch S, Horesh N, Apter A.
    Compr Psychiatry; 2013 Jul 15; 54(5):467-73. PubMed ID: 23219489
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.